The Effect of Moringa oleifera Extract on Inflammatory Status in Cancer Patients with Aromatase-Induced Arthralgia
DOI:
https://doi.org/10.3889/oamjms.2023.10980Keywords:
Aromatase-induced arthralgia, Aromatase inhibitor, Breast cancer, Inflammatory response, Moringa oleifera, PainAbstract
BACKGROUND: Aromatase inhibitor therapy is commonly used for breast cancer patients with characteristics of positive estrogen and progesterone receptors test without metastases. Thus, this kind of therapy generally gives side effects of aromatase-induced arthralgia (AIA). Moringa oleifera has a strong anti-inflammatory substance that has the potential to reduce inflammation and pain in a patient with AIA.
AIM: This study aims to assess the effect of M. oleifera extract administration on pain response and inflammatory status in breast cancer with aromatase inhibitor-induced arthralgia patients.
METHODS: Forty-two patients breast cancer patients with estrogen and progesterone receptor-positive in Dr. Kariadi General Hospital were assessed for pain response and inflammatory status before and after the treatment with M. oleifera leaf extract for one month. Assessment of pain response is using the Australian Canadian osteoarthritis hand index (AUSCAN) questionnaire and inflammation is measured by ANA serum level. This study is experimental with two parallel pre-test and post-test group.
RESULTS: In the treatment group, there was a significant decrease of the AUSCAN score 13.5 ± 5.11 (p ≤ 0.001), while in the control group, there was an increase in the AUSCAN score 2.7 ± 4.96 (p = 0.022). In the measurement of ANA serum level, a significant decrease of the treatment group found 0.3 ± 0.40 (p ≤ 0.001).
CONCLUSIONS: Moringa oleifera extract can help reduce pain response and inflammatory status of patients with chronic inflammation as an additional therapy.
Downloads
Metrics
Plum Analytics Artifact Widget Block
References
Waks AG, Winer EP. Breast cancer treatment: A review. JAMA. 2019;321(3):288-300. https://doi.org/10.1001/jama.2018.19323 PMid:30667505 DOI: https://doi.org/10.1001/jama.2018.19323
Gnant M, Fitzal F, Rinnerthaler G, Steger GG, Greil-Ressler S, Balic M, et al. Duration of adjuvant aromatase-inhibitor therapy in postmenopausal breast cancer. N Engl J Med. 2021;385(5):395-405. https://doi.org/10.1056/nejmoa2104162 PMid:34320285 DOI: https://doi.org/10.1056/NEJMoa2104162
Lombard JM, Zdenkowski N, Wells K, Beckmore C, Reaby L, Forbes JF, et al. Aromatase inhibitor induced musculoskeletal syndrome: A significant problem with limited treatment options. Support Care Cancer. 2016;24(5):2139-46. https://doi.org/10.1007/s00520-015-3001-5 PMid:26556210 DOI: https://doi.org/10.1007/s00520-015-3001-5
Niravath P. Aromatase inhibitor-induced arthralgia: A review. Ann Oncol. 2013;24(6):1443-9. https://doi.org/10.1093/annonc/mdt037 DOI: https://doi.org/10.1093/annonc/mdt037
PMid:23471104
Gaillard S, Stearns V. Aromatase inhibitor-associated bone and musculoskeletal effects: New evidence defining etiology and strategies for management. Breast Cancer Res. 2011;13(2):205. https://doi.org/10.1186/bcr2818 PMid:21457526 DOI: https://doi.org/10.1186/bcr2818
Mao JJ, Chung A, Benton A, Hill S, Ungar L, Leonard CE, et al. Online discussion of drug side effects and discontinuation among breast cancer survivors. Pharmacoepidemiol Drug Saf. 2013;22(3):256-62. https://doi.org/10.1002/pds.3365 PMid:23322591 DOI: https://doi.org/10.1002/pds.3365
Hyder T, Marino CC, Ahmad S, Nasrazadani A, Brufsky AM. Aromatase inhibitor-associated musculoskeletal syndrome: Understanding mechanisms and management. Front Endocrinol (Lausanne). 2021;12:713700. https://doi.org/10.3389/fendo.2021.713700 PMid:34385978 DOI: https://doi.org/10.3389/fendo.2021.713700
Andrikopoulou A, Fiste O, Liontos M, Dimopoulos MA, Zagouri F. Aromatase and CDK4/6 inhibitor-induced musculoskeletal symptoms: A systematic review. Cancers (Basel). 2021;13(3):465. https://doi.org/10.3390/cancers13030465 PMid:33530456 DOI: https://doi.org/10.3390/cancers13030465
Irwan Z. Kandungan Zat Gizi Daun Kelor (Moringa Oleifera) Berdasarkan Metode Pengeringan. Jurnal Kesehatan Manarang. 2020;6(1):69-77. DOI: https://doi.org/10.33490/jkm.v6i1.231
Rachmawati SR, Suriawati J. Identifikasi senyawa kimia dan nilai gizi ekstrak air daun kelor (Moringa Oleifera L.) sebagai pengawet alami mie basah. SANITAS J Teknologi Dan Seni Kesehatan. 2019;10(2):102-16. https://doi.org/10.36525/sanitas.2019.11 DOI: https://doi.org/10.36525/sanitas.2019.11
Bamagous GA, Al Ghamdi S, Ibrahim IA, Mahfoz AM, Afify MA, Alsugoor MH, et al. Antidiabetic and antioxidant
activity of ethyl acetate extract fraction of Moringa oleifera leaves in streptozotocin-induced diabetes rats via inhibition of inflammatory mediators. Asian Pac J Trop Biomed. 2018;8(6):320-7. https://doi.org/10.4103/2221-1691.235327 DOI: https://doi.org/10.4103/2221-1691.235327
Joung H, Kim B, Park H, Lee K, Kim HH, Sim HC, et al. Fermented Moringa oleifera decreases hepatic adiposity and ameliorates glucose intolerance in high-fat diet-induced obese mice. J Med Food. 2017;20(5):439-47. https://doi.org/10.1089/jmf.2016.3860 PMid:28504910 DOI: https://doi.org/10.1089/jmf.2016.3860
Kim Y, Wu AG, Jaja-Chimedza A, Graf BL, Waterman C, Verzi MP, et al. Isothiocyanate-enriched moringa seed extract alleviates ulcerative colitis symptoms in mice. PLoS One. 2017;12(9):e0184709. https://doi.org/10.1371/journal.pone.0184709 PMid:28922365 DOI: https://doi.org/10.1371/journal.pone.0184709
Kooltheat N, Sranujit RP, Luetragoon T, Yuchat M,Adulyaritthikul P, Chaisomboon C, et al. Moringa oleifera lam. leaves extract reduces human T-cell hyporesponsiveness and DNA damage induced by oxidative stress. Int J Res Ayurveda Pharm. 2017;8(3):84-90. https://doi.org/10.7897/2277-4343.083149 DOI: https://doi.org/10.7897/2277-4343.083149
Martínez-González CL, Martínez L, Martínez-Ortiz EJ, González- Trujano ME, Déciga-Campos M, Ventura-Martínez R, et al. Moringa oleifera, a species with potential analgesic and anti- inflammatory activities. Biomed Pharmacother. 2017;87:482-8. https://doi.org/10.1016/j.biopha.2016.12.107 PMid:28073097 DOI: https://doi.org/10.1016/j.biopha.2016.12.107
Mohamed MA, Ibrahim MT, Abdel-Azim NS, El-Missiry M. Chemical and biological studies on Moringa oleifera L. cultivated in Egypt. Egypt Pharm J. 2021;20(1):33-41. DOI: https://doi.org/10.4103/epj.epj_37_20
Kumar G, Tuli HS, Mittal S, Shandilya JK, Tiwari A, Sandhu SS. Isothiocyanates: A class of bioactive metabolites with chemopreventive potential. Tumour Biol. 2015;36(6):4005-16. https://doi.org/10.1007/s13277-015-3391-5 PMid:25835976 DOI: https://doi.org/10.1007/s13277-015-3391-5
Esteve M. Mechanisms underlying biological effects of cruciferous glucosinolate-derived isothiocyanates/indoles: A focus on metabolic syndrome. Front Nutr. 2020;7:111. https://doi.org/10.3389/fnut.2020.00111 PMid:32984393 DOI: https://doi.org/10.3389/fnut.2020.00111
Saleh HA, Yousef MH, Abdelnaser A. The anti-inflammatory properties of phytochemicals and their effects on epigenetic mechanisms involved in TLR4/NF-κB-mediated inflammation. Front Immunol. 2021;12:606069. https://doi.org/10.3389/fimmu.2021.606069 PMid:33868227 DOI: https://doi.org/10.3389/fimmu.2021.606069
Lucarini E, Micheli L, di Cesare Mannelli L, Ghelardini C. Naturally occurring glucosinolates and isothiocyanates as a weapon against chronic pain: Potentials and limits. Phytochem Rev. 2022;21(2):647-65. https://doi.org/10.1007/s11101-022-09809-0 DOI: https://doi.org/10.1007/s11101-022-09809-0
Downloads
Published
How to Cite
License
Copyright (c) 2023 Mada Aji Prakoso, Yan Wisnu Prajoko, Hardian Hardian, Trilaksana Nugroho, Yora Nindita (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
http://creativecommons.org/licenses/by-nc/4.0
